Epidarex Capital

Epidarex Capital company information, Employees & Contact Information

Explore related pages

Related company profiles:

Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.

Company Details

Employees
17
Founded
-
Address
7910 Woodmont Avenue, Suite 1315,united Kingdom
Phone
301 298 5455
Email
in****@****rex.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Bethesda, Maryland
Looking for a particular Epidarex Capital employee's phone or email?

Epidarex Capital Questions

News

Epidarex Capital Targets UK Biotech with €112M Venture Fund - Labiotech.eu

Epidarex Capital Targets UK Biotech with €112M Venture Fund Labiotech.eu

Transatlantic Epidarex banks $126M to back U.K. biotech startups - Fierce Biotech

Transatlantic Epidarex banks $126M to back U.K. biotech startups Fierce Biotech

Venture Capital Firm Epidarex Closes New Life Sciences Fund Worth $126 Million - BioSpace

Venture Capital Firm Epidarex Closes New Life Sciences Fund Worth $126 Million BioSpace

LUNAC Therapeutics develops the next generation anticoagulants and announces fundings - drugdiscoverytrends.com

LUNAC Therapeutics develops the next generation anticoagulants and announces fundings drugdiscoverytrends.com

Intuitive Ventures recruits Burke as senior partner and Jaffe as venture advisor - Venture Capital Journal

Intuitive Ventures recruits Burke as senior partner and Jaffe as venture advisor Venture Capital Journal

Dr. Falk Pharma acquires spinout Kynos Therapeutics to develop its novel KMO inhibitors for acute pancreatitis - scottish-enterprise-mediacentre.com

Dr. Falk Pharma acquires spinout Kynos Therapeutics to develop its novel KMO inhibitors for acute pancreatitis scottish-enterprise-mediacentre.com

Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology - PR Newswire

Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology PR Newswire

Epidarex Capital launches £102m venture fund in Edinburgh to support life science firms - Scottish Financial News

Epidarex Capital launches £102m venture fund in Edinburgh to support life science firms Scottish Financial News

Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory - researchgate.net

Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory researchgate.net

Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor - scottish-enterprise-mediacentre.com

Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor scottish-enterprise-mediacentre.com

Venture capital firm welcomes potential billion-dollar deal - The Herald

Venture capital firm welcomes potential billion-dollar deal The Herald

Top Epidarex Capital Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant